ImmuDyne Announces Appointment of Amilya Antonetti as Chief Digital Strategist
NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader in the development and online marketing of OTC health and wellness products addressing large unmet needs, today announces that Amilya Antonetti has accepted a position as an advisor to the company.
Ms. Antonetti is a prominent television host and human behavior expert. A former contributor to Fox News and CNBC, she regularly appears on many of America’s largest television talk shows, cable news networks and national talk radio. She brings her 30 plus years of brand building and expertise as a digital strategist to the Immudyne team. Additionally, Ms. Antonetti has deep experience in online direct marketing and influencer marketing, two very important areas of focus for ImmuDyne in 2018.
Ms. Antonetti is particularly passionate about the inevitable growth opportunity for e-commerce and especially companies like Immudyne that own and operate online brands that are superior to what is found in traditional brick and mortar retailers.
“In the U.S., e-commerce is growing approximately 10% per year, representing approximately $400B in overall sales revenue,” stated Ms. Antonetti. “In 2017, Credit Suisse forecasts that in the U.S. 8,640 brick-and-mortar store locations will shut their doors. E-tailers like ImmuDyne, as opposed to traditional retailers, can quickly launch proprietary brands that can be marketed directly to the global consumer via platforms like Facebook, Google and Amazon. It’s an extremely targeted, scalable and efficient business model that eliminates many of the logistical and operational expenses typically found in traditional brick and mortar retailers. Direct to consumer can also facilitate enhanced consumer experience as we use today's technology to better learn and serve our customers.”
“ImmuDyne is thrilled to have someone with Ms. Antonetti’s experience and relationships on the team,” stated Stefan Galluppi, CMO and Director of Immudyne. “We believe she will add a tremendous amount of value as we continue to grow our portfolio of online brands in 2018 and beyond.”
lmmuDyne, Inc. (the "Company") is a health and wellness company that develops, manufactures, and markets innovative consumer products in the health and wellness sector. ImmuDyne manufactures and markets a proprietary and patent protected Yeast Beta Glucan ingredient that has been shown in thousands of clinical studies to support and regulate the human immune system. It has broad applications in skincare and as an immune support supplement. Immudyne PR, a majority owned subsidiary of ImmuDyne, Inc., is the digital marketing arm of Immudyne and is currently focused on marketing products for thicker and fuller hair (Shapiro MD) and a skincare line containing Immudyne’s proprietary Yeast Beta Glucan ingredient (Inate MD). All of lmmuDyne's intellectual property is protected by patents and/or trade secrets. Additional information can be found on the web at www.immudyne.com.
Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release, including projections with respect to lmmuDyne's results of operations, may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.
Investor Relations Contact:
Released December 5, 2017